Paxlovid
| CAS No. | 2628280-40-8 | Cat. No. | BCP40653 |
| Name | Paxlovid | ||
| Synonyms | PF 07321332; PF07321332;PF-07321332; | ||
| Formula | C23H32F3N5O4 | M. Wt | 499.53 |
| Description | PF-07321332 is an orally bioavailable 3C-like protease (3CLPRO) inhibitor. This drug is being investigated for safety, tolerability, and pharmacokinetics before moving on to studies of efficacy in the treatment or prophylaxis of COVID-19. 3CLPRO is responsible for cleaving polyproteins 1a and 1ab of SARS-CoV-2. PF-07321332 is an oral COVID-19 antiviral clinical candidate. By inhibiting the main protease, PF-07321332 prevents the virus from cleaving long protein chains into the parts it needs to reproduce itself. | ||
| Pathways | Microbiology/Virology | ||
| Targets | SARS CoV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.